跳至主要内容
临床试验/NCT02048683
NCT02048683已完成2 期

A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2013年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
24
试验地点
1
主要终点
Determination of plasmatic concentrations of sevoflurane

研究概览

简要总结

Comparing a pharmacokinetic model of a short sevoflurane sedation in burn ICU patients with control ICU patients.

详细描述

Prospective clinical study in ICU with sedated ventilated patients with sevoflurane with the AnaConda® system, establishing pharmacokinetic model of sevoflurane and its metabolites (hydroxyfluroisopropanol, fluoride) comparing burn and non burn ICU patients

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients ventilated requiring invasive procedure in ICU
  • •Stable respiratory and hemodynamic conditions
  • •Consent of patients or family
  • •Arterial line
  • •Burn patients : burn area between 20 and 50% (3rd degree) OR non burn patients

排除标准

  • •Sevoflurane anaphylaxia

研究组 & 干预措施

burn ICU patients

Experimental

Determination of plasmatic concentrations of sevoflurane at different times of a short term sedation of sevoflurane in burn versus non burn ICU patients

干预措施: Short term sedation with sevoflurane in ICU (Drug)

non burn ICU patients

Other

Determination of plasmatic concentrations of sevoflurane at different times of a short term sedation of sevoflurane in burn versus non burn ICU patients

干预措施: Short term sedation with sevoflurane in ICU (Drug)

结局指标

主要结局

Determination of plasmatic concentrations of sevoflurane

时间窗: at 5min, 15 min, 60 min and just before the end of sedation.

次要结局

  • Determination of plasmatic concentrations of HFIP and fluoride(at 5min, 15 min, 60 min and just before the end of sedation. And 5min, 10 min, 30 min, 60 min and 120 min after the end of sedation)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验